![Jorge Plutzky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jorge Plutzky
Corporate Officer/Principal at
The Brigham & Women's Hospital, Inc.
Profile
Jorge Plutzky is currently the Co-Director of Preventive Cardiology at The Brigham & Women's Hospital, Inc. and a Member of the American Society for Clinical Investigation.
He previously served as an Independent Director at VIVUS, Inc. and Aegerion Pharmaceuticals, Inc. He was also a Director at Novelion Therapeutics, Inc. from 2016 to 2017.
Additionally, he is a Member of The Phi Beta Kappa Society.
Plutzky received his undergraduate degree from the University of Virginia and his doctorate from The University of North Carolina at Charlotte.
Jorge Plutzky active positions
| Companies | Position | Start |
|---|---|---|
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | 01/01/1996 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
Former positions of Jorge Plutzky
| Companies | Position | End |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Director/Board Member | 01/08/2017 |
| AEGERION PHARMACEUTICALS, INC. | Director/Board Member | 29/11/2016 |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Corporate Officer/Principal | - |
| VIVUS, INC. | Director/Board Member | - |
Training of Jorge Plutzky
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Commercial Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
- Stock Market
- Insiders
- Jorge Plutzky
